Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
Savoia
Paola
P
Department of Medical Sciences and Human Oncology, Section of Dermatology, University of Turin, Turin, Italy. paolo.saviola@unito.it
Ortoncelli
Michela
M
Quaglino
Pietro
P
Bernengo
Maria Grazia
MG
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D018223:Dermatofibrosarcoma / Q000175:diagnosis / Q000188:drug therapy*; D003952:Diagnostic Imaging; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D013909:Thorax
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate